US Bancorp
LJPC

US Bancorp’s La Jolla Pharmaceutical Company LJPC Stock Holding History

US Bancorp’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,367
Closed -$6K – 4016
2020
Q1 		$6K Buy
+1,367
New +$8.63K ﹤0.01% 3229
2019
Q2 		– Sell
-596
Closed -$4K – 3770
2019
Q1 		$4K Buy
+596
New +$3.88K ﹤0.01% 3327
2018
Q4 		– Sell
-626
Closed -$13K – 3847
2018
Q3 		$13K Buy
626
+447
+250% +$11.7K ﹤0.01% 3051
2018
Q2 		$5K Buy
+179
New +$5.53K ﹤0.01% 3351

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

US Bancorp's LJPC Position: Q2 2020 in Review

US Bancorp sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 1,367 shares — an estimated $6K sold.

US Bancorp first reported a position in LJPC in Q2 2018 and held it in 4 quarters. The position peaked at $13K in Q3 2018. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • US Bancorp reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • US Bancorp sold 1,367 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $6K.
  • US Bancorp first reported a position in La Jolla Pharmaceutical Company in Q2 2018 and held it in 4 quarters.
  • US Bancorp's La Jolla Pharmaceutical Company position peaked at $13K in Q3 2018.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on US Bancorp's 13F filing for Q2 2020, filed 7 Aug 2020.